APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis

Journal of Clinical Investigation

Volumn 121, Issue 11, 2011, Pages 4526-4536

  Ding, Qingqing ^a   Chang, Chun Ju ^a   Xie, Xiaoming ^a   Xia, Weiya ^a   Yang, Jer Yen ^a,b   Wang, Shao Chun ^c   Wang, Yan ^a   Xia, Jiahong ^d   Chen, Libo ^d   Cai, Changchung ^e   Li, Huabin ^f   Yen, Chia Jui ^g   Kuo, Hsu Ping ^a,b   Lee, Dung Fang ^a,b   Lang, Jingyu ^a   Huo, Longfei ^a   Cheng, Xiaoyun ^a,b   Chen, Yun Ju ^a,h   Li, Chia Wei ^a   Jeng, Long Bin ⁱ   Hsu, Jennifer L ^a,h   Li, Long Yuan ^h,j   Tan, Alai ^k   Curley, Steven A ^a   Ellis, Lee M ^a   DuBois, Raymond N ^a   Hung, Mien Chie ^a,b,h   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e QINGDAO UNIVERSITY   (China)

^f SUN YAT SEN UNIVERSITY   (China)

^g NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^h Graduate Institute of Cancer Biology   (Taiwan)

ⁱ CHINA MEDICAL UNIVERSITY   (Taiwan)

^j ASIA UNIVERSITY   (Taiwan)

^k UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CATHEPSIN K; CD133 ANTIGEN; GELATINASE A; K RAS PROTEIN; LIVER TRIACYLGLYCEROL LIPASE; PROTEIN; S100P PROTEIN; STROMELYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REPRESSION; GENE EXPRESSION; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTIDINE DEAMINASE; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS;

EID: 80555146748     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI45008     Document Type: Article

References (46)

1. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med. 2008;359(26):2814-2823.
2. Curley SA, Izzo F, Abdalla E, Vauthey JN. Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev. 2004;23(1-2):165-182. (Pubitemid 38221602)
3. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93(9):1115-1122. (Pubitemid 44343509)
4. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254-259. (Pubitemid 44305540)
5. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99(6):433-441. (Pubitemid 47073566)
6. Dashwood RH. Early detection and prevention of colorectal cancer (review). Oncol Rep. 1999; 6(2):277-281.
7. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3(6):453-458. (Pubitemid 37328849)
8. Weinberg RA. Leaving home early: reexamination of the canonical models of tumor progression. Cancer Cell. 2008;14(4):283-284.
9. Bos PD, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009; 459(7249):1005-1009.
10. Minn AJ, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436(7050):518-524. (Pubitemid 41112921)
11. Yang J, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117(7):927-939. (Pubitemid 38798858)
12. Zhang B, et al. Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology. 2010;138(3):969-980.
13. Stein U, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009;15(1):59-67.
14. Sonoshita M, et al. Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell. 2011;19(1):125-137.
15. Halder SK, Rachakonda G, Deane NG, Datta PK. Smad7 induces hepatic metastasis in colorectal cancer. Br J Cancer. 2008;99(6):957-965.
16. Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976;36(12):4562-4569.
17. Calin GA, Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene. 2006;25(46):6202-6210. (Pubitemid 44527851)
18. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med. 2006;12(12):580-587. (Pubitemid 44780201)
19. Huang J, Liang Z, Yang B, Tian H, Ma J, Zhang H. Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members. J Biol Chem. 2007;282(46):33632-33640. (Pubitemid 350159510)
20. Zhang H. The Inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and Its family members on the activity of cellular microRNAs. Prog Mol Subcell Biol. 2010;50:71-83.
21. Gallois-Montbrun S, et al. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol. 2007;81(5):2165-2178.
22. Rhoads RE. miRNA regulation of the translational machinery. Preface. Prog Mol Subcell Biol. 2010; 50:v-vi.
23. Wichroski MJ, Robb GB, Rana TM. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog. 2006;2(5):e41.
24. Kang Y, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3(6):537-549. (Pubitemid 36808649)
25. Smith JJ, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010;138(3):958-968.
26. Pantaleo MA, et al. Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer. 2008; 99(10):1729-1734.
27. Wang G, et al. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res. 2006;66(2):1199-1207. (Pubitemid 43165991)
28. Saleem M, et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci U S A. 2006; 103(40):14825-14830. (Pubitemid 44527813)
29. Beer DG, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 2002;8(8):816-824.
30. Jiang L, et al. Targeting S100P inhibits colon cancer growth and metastasis by lentivirus-mediated RNA interference and proteomic analysis. Mol Med. 2011;17(7-8):709-716.
31. Fuentes MK, et al. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum. 2007;50(8):1230-1240. (Pubitemid 47087458)
32. Peichev M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95(3):952-958. (Pubitemid 30062717)
33. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106-110. (Pubitemid 46067310)
34. Singh SK, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396-401. (Pubitemid 39551674)
35. Shimada M, et al. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol. 2010;45(8):896-902.
36. Rappa G, Fodstad O, Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells. 2008;26(12):3008-3017.
37. Shmelkov SV, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest. 2008;118(6):2111-2120. (Pubitemid 351872330)
38. LaBarge MA, Bissell MJ. Is CD133 a marker of metastatic colon cancer stem cells? J Clin Invest. 2008;118(6):2021-2024. (Pubitemid 351872322)
39. Watt MJ, Steinberg GR. Regulation and function of triacylglycerol lipases in cellular metabolism. Biochem J. 2008;414(3):313-325.
40. Wong H, Schotz MC. The lipase gene family. J Lipid Res. 2002;43(7):993-999. (Pubitemid 34760869)
41. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell. 2010;140(1):49-61.
42. Volinia S, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257-2261. (Pubitemid 43271657)
43. Cummins JM, et al. The colorectal microRNAome. Proc Natl Acad Sci U S A. 2006;103(10):3687-3692. (Pubitemid 43376616)
44. Calin GA, Croce CM. Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein- coding genes. Blood. 2009;114(23):4761-4770.
45. Xie X, et al. Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. Cancer Cell. 2007;12(1):52-65. (Pubitemid 47001785)
46. Ding Q, et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell. 2005;19(2):159-170. (Pubitemid 41019664)